Skip to main content
SpringerLink
Log in

Toxic Neuropathies

  • Chapter
  • First Online:
Biopsy Diagnosis of Peripheral Neuropathy

  • 2219 Accesses

Abstract

Exogenous substances that can cause peripheral nerve injury include pharmaceutical agents, heavy metals, industrial chemicals, and nutritional and biological toxins. If a history of toxic exposure is not obtained or an alternative etiology is under consideration, nerve biopsy might be performed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Alderson K (1992) Axonal swellings in human intramuscular nerves. Muscle Nerve 15:1284–1289

    CAS  PubMed  Google Scholar 

  • Aldridge WN (1992) The Toxic Oil Syndrome (TOS, 1981): from the disease towards a toxicological understanding of its aetiology and mechanism. Toxicol Lett 64(65):59–70

    PubMed  Google Scholar 

  • Allen N, Mendell JR, Billmaier DJ et al (1975) Toxic polyneuropathy due to methyl n-butyl ketone. An Industrial outbreak. Arch Neurol 32:209–218

    CAS  PubMed  Google Scholar 

  • Altenkirch HJ, Mager J, Stoltenburg G et al (1977) Toxic polyneuropathies after sniffing a glue thinner. J Neurol 214:137–152

    CAS  PubMed  Google Scholar 

  • Ansbacher LE, Bosch EP, Cancilla PA (1982) Disulfiram neuropathy: a neurofilamentous distal axonopathy. Neurology 32:424–428

    CAS  PubMed  Google Scholar 

  • Asbury K, Brown MJ (1980) The evolution of structural changes in distal axonopathies. In: Spencer PS, Schaumburg HH (eds) Experimental and clinical neurotoxicology. Williams & Wilkins, Baltimore, pp 179–192

    Google Scholar 

  • Azulay JP, Blin O, Valentin P et al (1993) Regression of allopurinol induced peripheral neuropathy after drug withdrawal. Eur Neurol 33:193–194

    CAS  PubMed  Google Scholar 

  • Behse F, Pach J, Dorndorf W (1972) Klinische, electrophysiologische und bioptische Befunde. Z Neurol 202:209–216

    CAS  PubMed  Google Scholar 

  • Berger A, Schaumburg H (2005) Human toxic neuropathy caused by industrial agents. In: Dyck PJ, Thomas PK (eds) Peripheral neuropathy. Elsevier-Saunders, Philadelphia, pp 2505–2525

    Google Scholar 

  • Berger AR, Schaumburg HH, Schoeder C et al (1992) Dose response, coasting and differential fiber vulnerability in human toxic neuropathy: a prospective study of pyridoxine neurotoxicity. Neurology 42:1367–1370

    CAS  PubMed  Google Scholar 

  • Berger AR, Arezzo JC, Schaumburg HH et al (1993) 2′,3′-Dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients. Neurology 43:358–362

    CAS  PubMed  Google Scholar 

  • Bergouignan FX, Vital C, Henry P et al (1988) Disulfiram neuropathy. J Neurol 235:382–383

    CAS  PubMed  Google Scholar 

  • Bilbao JM, Briggs SJ, Gray TA (1984) Filamentous axonopathy in disulfiram neuropathy. Ultrastruct Pathol 7:295–300

    CAS  PubMed  Google Scholar 

  • Bono A, Beghi E, Bogliun G et al (1993) Antiepileptic drugs and peripheral nerve function: a multicenter screening investigation of 141 patients with chronic treatment. Epilepsia 34:323–331

    CAS  PubMed  Google Scholar 

  • Bouche P, Lacomblez L, Leger JM et al (1989) Peripheral neuropathies during treatment with almitrine: report of 46 cases. J Neurol 236:29–33

    CAS  PubMed  Google Scholar 

  • Boudouresques J, Khalil R, Pellissier JF et al (1977) Polynevrite au decours d’une intoxication par l’amitriptyline. Nouv Presse Med 6:4070

    CAS  PubMed  Google Scholar 

  • Bouldin TW, Hall CD, Krigman MR (1980) Pathology of disulfiram neuropathy. Neuropathol Appl Neurobiol 6:155–160

    CAS  PubMed  Google Scholar 

  • Bradley WG, Lassman LP, Pearce GW, Walton JN (1970) The neuromyopathy of vincristine in man. Clinical, electrophysiological and pathological studies. J Neurol Sci 10:107–131

    CAS  PubMed  Google Scholar 

  • Buchthal F, Behse F (1979) Electrophysiology and nerve biopsy in men exposed to lead. Br J Ind Med 36:135–147

    CAS  PubMed Central  PubMed  Google Scholar 

  • Burns SM, Lange DJ, Jaffe I, Hays AP (1994) Axonal neuropathy in eosinophilia-myalgia syndrome. Muscle Nerve 17:293–298

    CAS  PubMed  Google Scholar 

  • Casey EB, Jelliffe AM, Le Quesne PM et al (1973) Vincristine neuropathy-clinical and electrophysiological observations. Brain 96:69–86

    CAS  PubMed  Google Scholar 

  • Castot et al (1991) Les Neuropathies peripheriques a l’allopurinol existent-elles? Therapie 46:391–392

    CAS  PubMed  Google Scholar 

  • Cavaletti G, Jakubowiak AJ (2010) Peripheral neuropathy during bortezomib treatment of multiple myeloma: a review of recent studies. Leuk Lymphoma 51:1178–1187

    CAS  PubMed  Google Scholar 

  • Cavaletti G, Cornblath DR, Merkies IS et al (2013) The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings. Ann Oncol 24:454–462

    CAS  PubMed Central  PubMed  Google Scholar 

  • Cavanagh JB, Fuller NH, Johnson HM et al (1974) The effects of thallium salts, with particular reference to the nervous system changes. A report of three cases. Q J Med 43:293–319

    CAS  PubMed  Google Scholar 

  • Chang CM, Yu CW, Fong KY et al (1993) N-hexane neuropathy in offset printers. J Neurol Neurosurg Psychiatry 56:538–542

    CAS  PubMed Central  PubMed  Google Scholar 

  • Chapon F, Lechevalier B, da Silva DC et al (1985) Neuropathies a la thalidomide. Rev Neurol 141:719–728

    CAS  PubMed  Google Scholar 

  • Charness ME, Morady F, Scheinman MM (1984) Frequent neurologic toxicity associated with amiodarone therapy. Neurology 34:669–671

    CAS  PubMed  Google Scholar 

  • Chaudhry V, Eisenberger MA, Sinibaldi VJ et al (1996) A prospective study of suramin-induced peripheral neuropathy. Brain 119(Part 6):2039–2052

    PubMed  Google Scholar 

  • Chaudhry V, Cornblath DR, Corse A et al (2002) Thalidomide-induced neuropathy. Neurology 59:1872–1875

    CAS  PubMed  Google Scholar 

  • Cho ES (1977) Toxic effects of adriamycin on the ganglia of the peripheral nervous system: a neuropathological study. J Neuropathol Exp Neurol 36:907–915

    CAS  PubMed  Google Scholar 

  • Collaborative Group for the Study of Polyneuropathy (1994) Antiarrhythmic drugs and polyneuropathy. J Neurol Neurosurg Psychiatry 57:340–343

    Google Scholar 

  • Critchley EMR (1987) Neuropathies due to drugs. In: Matthews WB (ed) Neuropathies, vol 51, Handbook of clinical neurology. Elsevier Science Publishers, Amsterdam, pp 293–314

    Google Scholar 

  • Davenport JG, Farrell DF, Sumi SM (1976) “Giant Axonal Neuropathy” caused by industrial chemicals: neurofilamentous axonal masses in man. Neurology 26:919–923

    CAS  PubMed  Google Scholar 

  • Diezi M, Buclin T, Kuntzer T (2013) Toxic and drug-induced peripheral neuropathies: updates on causes, mechanisms and management. Curr Opin Neurol 26:481–488

    CAS  PubMed  Google Scholar 

  • Donaghy M, Rushworth G, Jacobs JM (1991) Generalized peripheral neuropathy in a dental technician exposed to methyl methacrylate monomer. Neurology 41:1112–1116

    CAS  PubMed  Google Scholar 

  • Donofrio PD, Wilbourn AJ, Albers JW et al (1987) Acute arsenic intoxication presenting as Guillain-Barre-like syndrome. Muscle Nerve 10:114–120

    CAS  PubMed  Google Scholar 

  • Donofrio PD, Stanton C, Miller VS et al (1992) Demyelinating polyneuropathy in Eosinophilia-Myalgia syndrome. Muscle Nerve 15:796–805

    CAS  PubMed  Google Scholar 

  • Dubois A, Blin B, Bosc C et al (1984) A propos des neuropathies a l’amiodarone. Presse Med 13:1338–1339

    CAS  PubMed  Google Scholar 

  • Dupuy B, Lechevalier B, Berthelin C et al (1984) Etude du nerf peripherique dans un cas de neuropathie saturnine. Rev Neurol 140:406–414

    CAS  PubMed  Google Scholar 

  • Ehle AL (1986) Lead neuropathy and electrophysiological studies in low level lead exposure: a critical review. Neurotoxicology 7:203–216

    CAS  PubMed  Google Scholar 

  • Fardeau M, Tome FMS, Simon P (1979) Muscle and nerve changes induced by perhexiline maleate in man and mice. Muscle Nerve 2:24–36

    CAS  PubMed  Google Scholar 

  • Fleming FJ, Vytopil M, Chaitow J et al (2005) Thalidomide neuropathy in childhood. Neuromuscul Disord 15:172–176

    PubMed  Google Scholar 

  • Frasca V, Riazza BS, Matthews RG (1986) In vivo inactivation of methionine synthase by nitrous oxide. J Biol Chem 261:15823–15826

    CAS  PubMed  Google Scholar 

  • Fraser AG, McQueen IN, Watt AH et al (1985) Peripheral neuropathy during long-term high-dose amiodarone therapy. J Neurol Neurosurg Psychiatry 48:576–578

    CAS  PubMed Central  PubMed  Google Scholar 

  • Freimer ML, Glass JD, Chaudhry V et al (1992) Chronic demyelinating neuropathy associated with eosinophilia-myalgia syndrome. J Neurol Neurosurg Psychiatry 55:352–358

    CAS  PubMed Central  PubMed  Google Scholar 

  • Fullerton PM (1966) Chronic peripheral neuropathy produced by lead poisoning in Guinea-pigs. J Neuropathol Exp Neurol 25:214–236

    CAS  PubMed  Google Scholar 

  • Fullerton PM (1969) Electrophysiological and histological observations on peripheral nerves in acrylamide poisoning in man. J Neurol Neurosurg Psychiatry 32:186–192

    CAS  PubMed Central  PubMed  Google Scholar 

  • Fullerton PM, O’Sullivan DJ (1968) Thalidomide neuropathy: a clinical, electrophysiological and histological follow-up. J Neurol Neurosurg Psychiatry 31:543–551

    CAS  PubMed Central  PubMed  Google Scholar 

  • Gastaut JL, Pellissier JF (1984) Neuropathie au cisplatine, etude clinique electrophysiologique et morphologique. Rev Neurol 141:614–626

    Google Scholar 

  • Gherardi R, Baudrimont M, Gray F et al (1987) Almitrine neuropathy. A nerve biopsy study of 8 cases. Acta Neuropathol 73:202–208

    CAS  PubMed  Google Scholar 

  • Giannini F, Volpi N, Rossi S et al (2003) Thalidomide-induced neuropathy: a ganglionopathy? Neurology 60:877–878

    CAS  PubMed  Google Scholar 

  • Gold BG, Griffin JW, Price D (1985) Slow axonal transport in acrylamide neuropathy: different abnormalities produced by single dose and continuous administration. J Neurosci 5:1755–1768

    CAS  PubMed  Google Scholar 

  • Goldstein N, McCall JT, Dyck PJ (1975) Metal neuropathy. In: Dyck PJ, Thomas PK, Lambert EH (eds) Peripheral neuropathy. WB Saunders, Philadelphia, pp 2133–2161

    Google Scholar 

  • Gonzalez E, Downey J (1972) Polyneuropathy in a glue sniffer. Arch Phys Med 53:333–337

    CAS  PubMed  Google Scholar 

  • Goto I, Matsumura M, Inoue N et al (1974) Toxic polyneuropathies after sniffing a glue thinner. J Neurol Neurosurg Psychiatry 37:848–853

    CAS  PubMed Central  PubMed  Google Scholar 

  • Gottfried MR, Graham DG, Morgan M et al (1985) The morphology of carbon disulfide neurotoxicity. Neurotoxicology 6:89–96

    CAS  PubMed  Google Scholar 

  • Gottschalk PG, Dyck PJ, Kiely JM (1968) Vinca alkaloid neuropathy: nerve biopsy studies in rats and man. Neurology 18:875–882

    CAS  PubMed  Google Scholar 

  • Graham DG, Szakal-Quin G, Priest JW et al (1984) In vitro evidence that covalent crosslinking of neurofilaments occurs in gamma-diketone neuropathy. Proc Natl Acad Sci U S A 81:4979–4982

    CAS  PubMed Central  PubMed  Google Scholar 

  • Green LS, Donoso JA, Heller-Bettinger IE et al (1977) Axonal transport disturbances in vincristine-induced peripheral neuropathy. Ann Neurol 1:255–262

    CAS  PubMed  Google Scholar 

  • Griffin JW, Price DL (1981) Demyelination in experimental IDPN and hexacarbon neuropathies: evidence for an axonal influence. Lab Invest 45:130–141

    CAS  PubMed  Google Scholar 

  • Grisold W, Cavaletti G, Windebank AJ (2012) Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention. Neuro Oncol 14(Suppl 4):iv45–iv54

    CAS  PubMed Central  PubMed  Google Scholar 

  • Gross JA, Haas ML, Swift TR (1990) Ethylene oxide neurotoxicity: report of four cases and review of the literature. Neurology 29:978–983

    Google Scholar 

  • Heath JW, Ueda S, Bornstein MB et al (1982) Buckthorn neuropathy in vitro: evidence for a primary neuronal defect. J Neuropathol Exp Neurol 41:204–220

    CAS  PubMed  Google Scholar 

  • Heiman-Patterson TD, Bird SJ, Parry GJ et al (1990) Peripheral neuropathy associated with eosinophilia-myalgia syndrome. Ann Neurol 28:522–528

    CAS  PubMed  Google Scholar 

  • Herskovitz S, Schaumburg HH (2005) Neuropathy caused by drugs. In: Thomas PK, Dyck P (eds) Peripheral neuropathy. Elsevier-Saunders, Philadelphia, pp 2553–2583

    Google Scholar 

  • Herskowitz A, Ishii N, Schaumburg HH (1981) n-Hexane neuropathy. A syndrome occurring as a result of industrial exposure. N Engl J Med 285:82–85

    Google Scholar 

  • Hruban Z (1984) Pulmonary and generalized lysosomal storage induced by amphiphilic drugs. Environ Health Perspect 55:53–76

    CAS  PubMed Central  PubMed  Google Scholar 

  • Hruban Z, Slesers A, Hopkins E (1972) Drug induced and naturally occurring myeloid bodies. Lab Invest 27:62–70

    CAS  PubMed  Google Scholar 

  • Jacobs JM, Costa-Jussa FR (1985) The pathology of amiodarone neurotoxicity. II. Peripheral neuropathy in man. Brain 108:753–769

    PubMed  Google Scholar 

  • Joy RJT, Scalettar R, Sodee DB (1960) Optic and peripheral neuritis. Probable effect of prolonged chloramphenicol therapy. JAMA 173:1731–1734

    CAS  PubMed  Google Scholar 

  • Kalyanaraman UP, Kalyanaraman K, Cullinan SA et al (1983) Neuromyopathy of cyanide intoxication due to “Laetrile” (amygdalin). A clinicopathologic study. Cancer 51(2126–2133):1983

    Google Scholar 

  • Kane FJ (1970) Carbon disulfide intoxication from overdosage of disulfiram. Am J Psychiatry 127:690–694

    PubMed  Google Scholar 

  • Kannan R, Sarma JSM, Guha M et al (1991) Amiodarone toxicity: II. Desmethylamiodarone induced phospholipidosis and ultrastructural changes during repeated administration in rats. Fundam Appl Toxicol 16:103–109

    CAS  PubMed  Google Scholar 

  • Kaplan JG, Kessler J, Rosenberg N et al (1993) Sensory neuropathy associated with Dursban (Chlorpyrifos) exposure. Neurology 43:2193–2196

    CAS  PubMed  Google Scholar 

  • Katrak S, Pollock M, O’Brien CP et al (1980) Clinical and morphological features of gold neuropathy. Brain 103:671–693

    CAS  PubMed  Google Scholar 

  • Kaufman LD, Seidman RJ, Gruber BL (1990a) L-tryptophan-associated eosinophilic perimyositis, neuritis, and fasciitis. A clinicopathologic and laboratory study of 25 patients. Medicine 69:187–199

    CAS  PubMed  Google Scholar 

  • Kaufman LD, Finn AF Jr, Seidman RJ et al (1990b) Eosinophilic neuritis, perimyositis, and vasculitis associated with ingestion of L-tryptophan. J Rheumatol 17:795–800

    CAS  PubMed  Google Scholar 

  • Kilbourne EM (1992) Eosinophilia-myalgia syndrome: coming to grips with a new illness. Epidemiol Rev 14:16–36

    CAS  PubMed  Google Scholar 

  • Kilbourne EM, Rigau-Perez JG, Heath CW et al (1983) Clinical epidemiology of toxic-oil syndrome. Manifestations of a new illness. N Engl J Med 309:1408–1414

    CAS  PubMed  Google Scholar 

  • King RH, Sarsilmaz M, Thomas PK et al (1993) Axonal neurofilamentous accumulations: a comparison between human and canine giant axonal neuropathy and 2,5-HD neuropathy. Neuropathol Appl Neurobiol 19:224–232

    CAS  PubMed  Google Scholar 

  • Korobkin R, Asbury AK, Sumner AJ et al (1975) Glue sniffing neuropathy. Arch Neurol 32:158–162

    CAS  PubMed  Google Scholar 

  • Krause KH, Berlit P (1990) Nerve conduction velocity in patients under long term treatment with antiepileptic drugs. Electromyogr Clin Neurophysiol 30:61–64

    CAS  PubMed  Google Scholar 

  • Kuncl RW, Duncan G, Watson D et al (1987) Colchicine myopathy and neuropathy. N Engl J Med 316:1562–1568

    CAS  PubMed  Google Scholar 

  • Lampert PW, Schochet SS (1968) Demyelination and remyelination in lead neuropathy. J Neuropathol Exp Neurol 27:527–545

    CAS  PubMed  Google Scholar 

  • LaPointe NE, Morfini G, Brady ST et al (2013) Effects of eribulin, vincristine, paclitaxel and ixabepilone on fast axonal transport and kinesin-1 driven microtubule gliding: implications for chemotherapy-induced peripheral neuropathy. Neurotoxicology 37:231–239

    CAS  PubMed Central  PubMed  Google Scholar 

  • LaRocca RV, Meer J, Gilliatt RW et al (1990) Suramin induced polyneuropathy. Neurology 40:954–960

    CAS  Google Scholar 

  • LeWitt PA (1980) The neurotoxicity of the rat poison Vacor. N Engl J Med 302:73–77

    CAS  PubMed  Google Scholar 

  • LeWitt PA, Forno LS (1985) Peripheral neuropathy following amitriptyline overdose. Muscle Nerve 8:723–724

    CAS  PubMed  Google Scholar 

  • Lipton RB, Apfel SC, Dutcher JP et al (1989) Taxol produces a predominantly sensory neuropathy. Neurology 39:368–373

    CAS  PubMed  Google Scholar 

  • Lovelace RE, Horowitz SJ (1968) Peripheral neuropathy in long term diphenylhydantoin therapy. Arch Neurol 18:69–77

    CAS  PubMed  Google Scholar 

  • Lullmann H, Lullmann-Rauch R, Wassermann O (1978) Lipidosis induced by amphiphilic cationic drugs. Biochem Pharmacol 27:1103–1108

    CAS  PubMed  Google Scholar 

  • Manji H (2013) Drug-induced neuropathies. Chapter 42. In: Said G, Krarup C (eds) Handbook of clinical neurology, vol 115 (3rd series), Peripheral nerve disorders. Elsevier BV, Amsterdam, pp 729–742

    Google Scholar 

  • Manzo L (2000) Thallium. In: Spencer PS, Schaumburg H (eds) Experimental and clinical neurotoxicology. Oxford University Press, New York, pp 1168–1177

    Google Scholar 

  • Martin RW, Duffy J, Engel AG et al (1990) The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiology. Ann Intern Med 113:124–134

    CAS  PubMed  Google Scholar 

  • Martinez-Tello FJ, Tellez I (1991) Seminar on cardiovascular manifestations of the toxic oil syndrome and related conditions. II. Extracardiac vascular and neural lesions in the toxic oil syndrome. J Am Coll Cardiol 18:1043–1047

    CAS  PubMed  Google Scholar 

  • Mayeno AN, Belongia EA, Lin F et al (1992) 3-(phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome? Mayo Clin Proc 67:1134–1139

    CAS  PubMed  Google Scholar 

  • McLeod JG, Penny R (1969) Vincristine neuropathy: an electrophysiological and histological study. J Neurol Neurosurg Psychiatry 32:297–304

    CAS  PubMed Central  PubMed  Google Scholar 

  • Meier C, Kauer B, Muller U, Ludin HP (1979) Neuromyopathy during chronic amiodarone treatment. A case report. J Neurol 220:231–239

    CAS  PubMed  Google Scholar 

  • Melgaard B, Hansen HS, Kamieniecka Z et al (1982) Misonidazole neuropathy, a clinical electrophysiological and histological study. Ann Neurol 12:10–17

    CAS  PubMed  Google Scholar 

  • Melgaard B, Kohler O, Sand-Hansen H et al (1988) Misonidazole neuropathy. A prospective study. J Neurooncol 6:227–230

    CAS  PubMed  Google Scholar 

  • Mendell JR, Sahenk Z, Saida K et al (1977) Alterations of fast axoplasmic transport in experimental methyl-n-butyl ketone neuropathy. Brain Res 133:107–118

    CAS  PubMed  Google Scholar 

  • Moddel G, Bilbao JM, Payne D et al (1978) Disulfiram neuropathy. Arch Neurol 35:658–660

    CAS  PubMed  Google Scholar 

  • Mokri B, Ohnishi A, Dyck PJ (1981) Disulfiram neuropathy. Neurology 31:730–735

    CAS  PubMed  Google Scholar 

  • Monaco S, Autilio-Gambetti L, Lasek RJ et al (1989) Experimental increase of neurofilament transport rate: decreases in neurofilament number and in axon diameter. J Neuropathol Exp Neurol 48:23–32

    CAS  PubMed  Google Scholar 

  • Montgomery RD (1979) Cyanogenic glucosides. In: Vinken PJ, Bruyn GW (eds) Intoxications of the nervous system, vol 36, Handbook of clinical neurology. North-Holland Publishing Co., Amsterdam, pp 515–527

    Google Scholar 

  • Navarro JC, Rosales RL, Ordinario AT et al (1989) Acute dapsone-induced peripheral neuropathy. Muscle Nerve 12:604–606

    CAS  PubMed  Google Scholar 

  • Ng THK, Chan YW, Yu YL et al (1991) Encephalopathy and neuropathy following ingestion of a Chinese herbal broth containing podophyllin. J Neurol Sci 101:107–113

    CAS  PubMed  Google Scholar 

  • Nukada H, Pollock M (1981) Disulfiram neuropathy-a morphometric study of sural nerve. J Neurol Sci 51:51–67

    CAS  PubMed  Google Scholar 

  • O’Mahoney S, Keohane C, Jacobs J et al (1990) Neuropathy due to podophyllin intoxication. J Neurol 237:110–112

    Google Scholar 

  • Ochoa J (1970) Isoniazid neuropathy in man: quantitative electron microscope study. Brain 93:831–850

    CAS  PubMed  Google Scholar 

  • Ochs S, Brimijoin WS (1993) Axonal transport. In: Dyck PJ, Thomas PK et al (eds) Peripheral neuropathy, 3rd edn. WB Saunders, Philadelphia, pp 331–360

    Google Scholar 

  • Oh SJ (1975) Lead neuropathy: case report. Arch Phys Med Rehabil 56:312–317

    CAS  PubMed  Google Scholar 

  • Oh SJ, Kim JM (1976) Giant axonal swelling in “huffer’s” neuropathy. Arch Neurol 33:583–586

    CAS  PubMed  Google Scholar 

  • Ohnishi A, Peterson CM, Dyck PJ (1975) Axonal degeneration in sodium cyanate-induced neuropathy. Arch Neurol 32:530–534

    CAS  PubMed  Google Scholar 

  • Ohnishi A, Schilling K, Brimijoin WS et al (1977) Lead neuropathy. Part 1. Morphometry, nerve conduction and choline acetyltransferase transport. New finding of endoneurial edema associated with segmental demyelination. J Neuropathol Exp Neurol 36:499–518

    CAS  PubMed  Google Scholar 

  • Ortega-Benito JM (1992) Spanish toxic oil syndrome: ten years after the disaster. Public Health 106:3–9

    CAS  PubMed  Google Scholar 

  • Palakurthy PR, Iyer V, Meckler RJ (1987) Unusual neurotoxicity associated with amiodarone therapy. Arch Intern Med 147:881–884

    CAS  PubMed  Google Scholar 

  • Pappolla M, Penton R, Weiss HS et al (1987) Carbon disulfide axonopathy. Another experimental model characterized by acceleration of neurofilament transport and distinct changes of axonal size. Brain Res 424:272–280

    CAS  PubMed  Google Scholar 

  • Paulson JC, McClure WO (1975) Inhibition of axoplasmic transport by colchicine, podophyllotoxin and vinblastine: an effect on microtubules. Ann N Y Acad Sci 253:517–527

    CAS  PubMed  Google Scholar 

  • Pellissier JF, Pouget J, Cros D et al (1984) Peripheral neuropathy induced by amiodarone chlorhydrate. A clinicopathologic study. J Neurol Sci 63:251–266

    CAS  PubMed  Google Scholar 

  • Pestronk A, Keogh JP, Griffin JW (1980) Dimethylaminopropionitrile. In: Schaumburg HH, Spencer PS (eds) Experimental and clinical neurotoxicology. Williams & Wilkins, Baltimore, pp 422–429

    Google Scholar 

  • Peterson CM, Tsairis P, Ohnishi A et al (1974) Sodium cyanate induced neuropathy in patients with sickle cell anemia. Ann Intern Med 81:152–158

    CAS  PubMed  Google Scholar 

  • Philen RM, Hill RH Jr (1993) 3-(phenylamino)-alanine. A link between eosinophilia-myalgia syndrome and toxic oil syndrome? Mayo Clin Proc 68:197–200

    CAS  PubMed  Google Scholar 

  • Podratz JL, Knight AM, Ta LE et al (2011) Cisplatin induced mitochondrial DNA damage in dorsal root ganglion neurons. Neurobiol Dis 41:661–668

    CAS  PubMed Central  PubMed  Google Scholar 

  • Prickett CS, Johnson CD (1953) The in vivo production of carbon disulfide from tetraethylthiuram disulfide (Antabuse). Biochem Biophys Acta 12:542–546

    CAS  PubMed  Google Scholar 

  • Raeder EA, Podrid PJ, Lown B (1985) Side effects and complications of amiodarone therapy. Am Heart J 109:975–983

    CAS  PubMed  Google Scholar 

  • Ramirez JA, Mendell JR, Warmolts JR et al (1986) Phenytoin neuropathy: structural changes in the sural nerve. Ann Neurol 19:162–167

    CAS  PubMed  Google Scholar 

  • Raskin NH, Fishman RA (1965) Pyridoxine-deficiency neuropathy due to hydralazine. N Engl J Med 273:1182–1185

    CAS  PubMed  Google Scholar 

  • Ricoy JR, Cabello A, Rodrigues J et al (1983) Neuropathologic studies on the toxic syndrome related to adulterated rapeseed oil in Spain. Brain 106:817–835

    PubMed  Google Scholar 

  • Rizzuto W, Terzian H, Galiazzo-Rizzuto S (1977) Toxic polyneuropathies in Italy due to leather cement poisoning in shoe industries. A light and electron microscopic study. J Neurol Sci 31:343–354

    CAS  PubMed  Google Scholar 

  • Roelofs RI, Hrushesky W, Rogin J et al (1984) Peripheral sensory neuropathy and cisplatin chemotherapy. Neurology 34:934–938

    CAS  PubMed  Google Scholar 

  • Sahenk Z, Mendell JR, Corui D et al (1978) Polyneuropathy from inhalation of nitrous oxide cartridges through a whipped cream dispenser. Neurology 28:485–487

    CAS  PubMed  Google Scholar 

  • Sahenk Z, Brady ST, Mendell JR (1987) Studies on the pathogenesis of vincristine-induced neuropathy. Muscle Nerve 10:80–84

    CAS  PubMed  Google Scholar 

  • Sahenk Z, Barohn R, New P, Mendell JR (1994) Taxol neuropathy. Electrodiagnostic and sural nerve biopsy findings. Arch Neurol 51:726–729

    CAS  PubMed  Google Scholar 

  • Said G (1978) Perhexiline neuropathy: a clinicopathological study. Ann Neurol 3:259–266

    CAS  PubMed  Google Scholar 

  • Saifee TA, Elliott KJ, Lunn MP et al (2010) Bortezomib-induced inflammatory neuropathy. J Periph Nerv Syst 15:366–368

    Google Scholar 

  • Samuels ML, Leary WV, Alexanian R et al (1967) Clinical trials with N-isopropyl-a-(2-methylhydrazino)-p-toluamide hydrochloride in malignant lymphoma and other disseminated neoplasia. Cancer 20:1187–1194

    CAS  PubMed  Google Scholar 

  • Satsangi J, Donaghy M (1992) Multifocal peripheral neuropathy in eosinophilic fasciitis. J Neurol 239:91–92

    CAS  PubMed  Google Scholar 

  • Schaumburg HH, Berger AR (1993) Human toxic neuropathy due to industrial agents. In: Dyck PJ, Thomas PK et al (eds) Peripheral neuropathy, 3rd edn. WB Saunders, Philadelphia, pp 1553–1548

    Google Scholar 

  • Schaumburg HH, Kaplan J, Windebank A et al (1983) Sensory neuropathy from pyridoxine abuse. N Engl J Med 309:445–448

    CAS  PubMed  Google Scholar 

  • Schlenska GK, Spalke G (1975) Zur klinik und morphologie der bleipolyneuropathie des menschen. Nervenarzt 46:501–508

    CAS  PubMed  Google Scholar 

  • Schroder J (2000) Isoniazid. In: Spencer P, Schaumburg H (eds) Experimental and clinical neurotoxicology. Oxford University Press, New York, pp 690–697

    Google Scholar 

  • Schroder JM, Hoheneck M, Weis J, Deist H (1985) Ethylene oxide polyneuropathy: clinical follow-up study with morphometric and electron microscopic findings in a sural nerve biopsy. J Neurol 232:83–90

    CAS  PubMed  Google Scholar 

  • Seppalainen AM, Haltia M (1980) Carbon disulfide. In: Spencer PS, Schaumburg HH (eds) Experimental and clinical neurotoxicology. Williams & Wilkins, Baltimore, p 356

    Google Scholar 

  • Shelanski MI, Wisniewski H (1969) Neurofibrillary degeneration induced by vincristine therapy. Arch Neurol 20:199–206

    CAS  PubMed  Google Scholar 

  • Shinohara Y, Yamaguchi F, Gotoh F (1977) Toxic neuropathy as a complication of thiophenicol therapy. Eur Neurol 16:161–164

    CAS  PubMed  Google Scholar 

  • Shirabe T, Tsuda T, Terao A, Araki S (1974) Toxic polyneuropathy due to glue-sniffing. Report of two cases with a light and electron-microscopic study of the peripheral nerves and muscle. J Neurol Sci 21:101–113

    CAS  PubMed  Google Scholar 

  • Smith BE, Dyck PJ (1990) Peripheral neuropathy in the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Neurology 40:1035–1040

    CAS  PubMed  Google Scholar 

  • Smith SA, Roelofs RI, Gertner E (1990) Microangiopathy in the eosinophilia-myalgia syndrome. J Rheumatol 17:1544–1550

    CAS  PubMed  Google Scholar 

  • Spencer PS, Schaumburg HH (1977) Central peripheral distal axonopathy: the pathology of dying back polyneuropathies. In: Zimmerman H (ed) Progress in neuropathology. Grune & Stratton, New York, pp 253–295

    Google Scholar 

  • Spencer PS, Schaumburg HH (1978) Pathobiology of neurotoxic axonal degeneration. In: Waxman S (ed) Physiology and pathology of axons. Raven, New York, pp 265–282

    Google Scholar 

  • Spencer PS, Couri D, Schaumburg HH (1980) N-Hexane and Methyl-n-Butyl Ketone. In: Spencer PS, Schaumburg HH (eds) Experimental and clinical neurotoxicology. Williams & Wilkins, Baltimore, pp 456–475

    Google Scholar 

  • Swift TR, Gross JA, Ward LC, Crout BO (1981) Peripheral neuropathy in epileptic patients. Neurology 31:826–831

    CAS  PubMed  Google Scholar 

  • Takeuchi H, Takahashi M, Kang J et al (1980) Ethambutol neuropathy: clinical and electroneuromyographic studies. Folia Psychiatr Neurol Jpn 34:45–55

    CAS  PubMed  Google Scholar 

  • Takeuchi H, Yamada A, Touge T et al (1988) Metronidazole neuropathy: a case report. Jpn J Psychiatry Neurol 42:291–295

    CAS  PubMed  Google Scholar 

  • Tegner R, Tome FMS, Godeau P et al (1988) Morphological study of peripheral nerve changes induced by chloroquine treatment. Acta Neuropathol 75:253–260

    CAS  PubMed  Google Scholar 

  • Towfighi J, Gonatas NK, Pleasure D et al (1976) Glue sniffer’s neuropathy. Neurology 26:238–243

    CAS  PubMed  Google Scholar 

  • Urtasun RC, Chapman JD, Feldstein ML et al (1978) Peripheral neuropathy related to misonidazole: incidence and pathology. Br J Cancer 37(suppl III):271–275

    Google Scholar 

  • Van Rossum J, Roos RA, Bots GT (1984) Disulfiram polyneuropathy. Clin Neurol Neurosurg 86:81–87

    PubMed  Google Scholar 

  • Vanhooren G, Dehaene I, Van Zyndycke M et al (1990) Polyneuropathy in lithium intoxication. Muscle Nerve 13:204–208

    CAS  PubMed  Google Scholar 

  • Verheyen A, Peeraer E, Nuydens R et al (2012) Systemic antivascular endothelial growth factor therapies induce a painful sensory neuropathy. Brain 135(Pt 9):2629–2641

    PubMed  Google Scholar 

  • Vishnubhakat SM, Beresford HR (1991) Reversible myeloneuropathy of nitrous oxide abuse: serial electrophysiological studies. Muscle Nerve 14:22–26

    CAS  PubMed  Google Scholar 

  • Vital C, Vallat JM (1987a) Ultrastructural study of the human diseased peripheral nerve, 2nd edn. Elsevier, New York, p 185

    Google Scholar 

  • Vital C, Vallat JM (1987b) Ultrastructural study of the human diseased peripheral nerve, 2nd edn. Elsevier, New York, pp 179–182

    Google Scholar 

  • Watson DF, Griffin JW (1987) Vacor neuropathy: ultrastructural and axonal transport studies. J Neuropathol Exp Neurol 46:96–108

    CAS  PubMed  Google Scholar 

  • Watson PC, Ashby P, Bilbao JM (1980) Disulfiram neuropathy. Can Med Assoc J 123:123–126

    CAS  PubMed Central  PubMed  Google Scholar 

  • Weller RO, Mitchell J, Daves GD Jr (1980) Buckthorn (Karwinskia humboldtiana) toxins. In: Spencer PS, Schaumburg HH (eds) Experimental and clinical neurotoxicology. Williams & Wilkins, Baltimore, pp 336–347

    Google Scholar 

  • Williams AO, Osuntokun B (1969) Peripheral neuropathy in tropical (nutritional) ataxia in Nigeria. Light and electron microscopic study. Arch Neurol 21:475–492

    CAS  PubMed  Google Scholar 

  • Wilson JR, Conwit RA, Eidelman BH et al (1994) Sensorimotor neuropathy resembling CIDP in patients receiving FK506. Muscle Nerve 17:528–532

    CAS  PubMed  Google Scholar 

  • Windebank AJ (1993) Metal neuropathy. In: Dyck PJ, Thomas PK et al (eds) Peripheral neuropathy, 3rd edn. W.B. Saunders, Philadelphia, pp 1549–1570

    Google Scholar 

  • Windebank A (2005) Metal neuropathy. In: Dyck P, Thomas PK (eds) Peripheral neuropathy. Elsevier-Saunders, Philadelphia, pp 2527–2551

    Google Scholar 

  • Windebank AJ, Dyck PJ (1984) Lead intoxication as a model of primary segmental demyelination. In: Dyck PJ, Thomas PK et al (eds) Peripheral neuropathy, 2nd edn. WB Saunders, Philadelphia, pp 650–665

    Google Scholar 

  • Wulfhekel U, Dullmann J (1972) Ein Licht und elektronenoptischer. Beitrag Zur vinca alkaloid: polyneuropathie. Virchows Arch Abt A Path Anat 357:163–178

    CAS  Google Scholar 

  • Yiannikas C, Pollard JD, McLeod JG (1981) Nitrofurantoin neuropathy. Aust N Z J Med 11:400–405

    CAS  PubMed  Google Scholar 

  • Zheng H, Xiao WH, Bennett GJ (2011) Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy. Exp Neurol 232:154–161

    CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sunnybrook and St Michael’s Hospitals, University of Toronto, Toronto, ON, Canada

    Juan M. Bilbao MD, FRCP (C) (Professor Emeritus of Neuropathology)

  2. Division of Neuropathology Department of Pathology, Washington University School of Medicine, St. Louis, MO, USA

    Robert E. Schmidt MD, PhD (Professor of Pathology and Immunology Director)

Authors
  1. Juan M. Bilbao MD, FRCP (C)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert E. Schmidt MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Bilbao, J.M., Schmidt, R.E. (2015). Toxic Neuropathies. In: Biopsy Diagnosis of Peripheral Neuropathy. Springer, Cham. https://doi.org/10.1007/978-3-319-07311-8_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-07311-8_18

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-07310-1

  • Online ISBN: 978-3-319-07311-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation